Similar articles for PMID: 15865092

Year	Number of Results
1993	1
1995	1
1996	3
1997	3
1998	6
1999	8
2000	3
2001	5
2002	8
2003	9
2004	13
2005	19
2006	17
2007	16
2008	11
2009	7
2011	1
2012	1
2013	1
2014	2
2015	4
2016	1
2020	2
2021	0

1

Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.

Hashimoto K, Nio Y, Koike M, Itakura M, Yano S, Higami T, Maruyama R. Hashimoto K, et al. Anticancer Res. 2005 Mar-Apr;25(2B):1361-8. Anticancer Res. 2005. PMID: 15865092 Free article.

2

Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer.

Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M. Yamasawa K, et al. Clin Cancer Res. 2002 Aug;8(8):2563-9. Clin Cancer Res. 2002. PMID: 12171884 Free article.

3

Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.

Nio Y, Omori H, Hashimoto K, Itakura M, Koike M, Yano S, Toga T, Higami T, Maruyama R. Nio Y, et al. Anticancer Res. 2005 Sep-Oct;25(5):3523-9. Anticancer Res. 2005. PMID: 16101174 Free article.

4

Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma.

Jayasurya R, Sathyan KM, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, Nair MK, Kannan S. Jayasurya R, et al. Mod Pathol. 2005 Aug;18(8):1056-66. doi: 10.1038/modpathol.3800387. Mod Pathol. 2005. PMID: 15731778

5

p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.

Nio Y, Dong M, Uegaki K, Hirahara N, Minari Y, Sasaki S, Takamura M, Iguchi C, Tamura K. Nio Y, et al. Anticancer Res. 1998 Sep-Oct;18(5B):3773-9. Anticancer Res. 1998. PMID: 9854494

6

The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.

Tzai TS, Tsai YS, Chow NH. Tzai TS, et al. Urol Oncol. 2004 Mar-Apr;22(2):112-8. doi: 10.1016/S1078-1439(03)00176-5. Urol Oncol. 2004. PMID: 15082007

7

Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.

Ioachim E. Ioachim E. Int J Clin Pract. 2008 Nov;62(11):1736-43. doi: 10.1111/j.1742-1241.2006.01105.x. Int J Clin Pract. 2008. PMID: 19143860

8

Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.

Ioachim EE, Malamou-Mitsi V, Kamina SA, Goussia AC, Agnantis NJ. Ioachim EE, et al. Anticancer Res. 2000 Nov-Dec;20(6B):4221-5. Anticancer Res. 2000. PMID: 11205251

9

Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.

Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park Ti, Shin DG, Sohn KR, Lee KB. Sohn SK, et al. Am J Hematol. 2003 Jun;73(2):101-7. doi: 10.1002/ajh.10333. Am J Hematol. 2003. PMID: 12749011 Free article.

10

Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.

Rau B, Sturm I, Lage H, Berger S, Schneider U, Hauptmann S, Wust P, Riess H, Schlag PM, Dörken B, Daniel PT. Rau B, et al. J Clin Oncol. 2003 Sep 15;21(18):3391-401. doi: 10.1200/JCO.2003.07.077. Epub 2003 Jul 28. J Clin Oncol. 2003. PMID: 12885834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed